Previous research has shown that MCM7 promotes hepatocellular carcinoma (HCC) progression via the MCM7-cyclin D1 signaling pathway, suggesting its potential as a target for therapeutic intervention in hepatocellular carcinoma [18]. Here, MCM7 is linked to hepatocellular carcinoma.